Ocular Therapeutix, Inc. (NASDAQ:OCUL) In-Particular person and Digital Investor Day 2025 September 30, 2025 2:00 PM EDT
Firm Members
Pravin Dugel – Govt Chairman, President & CEO
Nadia Waheed – Chief Medical Officer
Jeffrey Heier, – Chief Scientific Officer
Namrata Saroj – Chief Enterprise Officer
Jay Robins – Senior Vice President, Finance
Peter Kaiser – Chief Growth Officer
William Slattery – Vice President of Investor Relations
Convention Name Members
Arshad Khanani – Sierra Eye Associates
Eleonora Lad – Duke College
Adnan Tufail – Moorfields
Patricio Schlottmann
Tara Bancroft – TD Cowen, Analysis Division
Biren Amin – Piper Sandler & Co., Analysis Division
Colleen Hanley – Robert W. Baird & Co. Included, Analysis Division
Sean McCutcheon – Raymond James & Associates, Inc., Analysis Division
Presentation
Operator
All proper. We’ll go forward and get began. Thanks all for becoming a member of us as we speak. We admire your curiosity in Ocular and look ahead to sharing the story with you. Earlier than I go the mic to Pravin, please notice that in as we speak’s presentation, we might be making forward-looking statements underneath the Personal Securities Litigation Reform Act of 1995. These statements are topic to quite a lot of dangers and uncertainties that might trigger precise outcomes to vary materially. Such dangers and uncertainties are detailed within the Threat Components part of our annual report on Kind 10-Okay and different filings with the SEC.
With that, it’s my pleasure to introduce Dr. Pravin Dugel, Ocular’s Govt Chairman, President and CEO.
Pravin Dugel
Govt Chairman, President & CEO
Thanks, Invoice, and welcome. Welcome to all of you. It is an thrilling day for us. You may have — you will see that we now have a really sturdy and informative Investor Day, and we have got nice audio system, panelists, et cetera. The final time we had one in every of these, it was proper right here on this room, and it was — I feel it was June 14 of final yr. And if you consider the place we have been then, and assume
